NCT06116903 (ExoGLIE) is a NA clinical trial of Blood sampling in Glioma, sponsored by University Hospital, Limoges.

Who is sponsoring NCT06116903?

NCT06116903 is sponsored by University Hospital, Limoges.

What drugs are being tested in NCT06116903?

Interventions in NCT06116903: Blood sampling.

Is NCT06116903 still recruiting?

NCT06116903 is currently recruiting now. Last updated 13 December 2024.

Last reviewed 2024-12-13 · How we verify

NCT06116903: ExoGLIE

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Clinical Relevance of Detecting Molecular Abnormalities in Glial Tumor Exosomes

Recruiting now NA Last updated 13 December 2024

What this trial tests

NA trial testing Blood sampling in Glioma in 60 participants. Currently enrolling.

Timeline

11 April 2024

Primary endpoint
15 May 2025

15 December 2025

Quick facts

Lead sponsor	University Hospital, Limoges
Phase	NA
Status	Recruiting now
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	diagnostic
Enrollment	60
Start date	11 April 2024
Primary completion	15 May 2025
Estimated completion	15 December 2025
Sites	1 location across France

Drugs / interventions tested

Blood sampling — full drug profile →

Conditions studied

Glioma — all drugs for Glioma →

Sponsor

University Hospital, Limoges

Who can join

18 and older, any sex, with Glioma. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this pilot study is that exosomes constitute a more interesting support for analyzes allowing a broader screening of molecular alterations to be carried out with more reliable, more sensitive and more efficient results than the reference Foundation One Liquid CDx test.

Publications & conference data

7 peer-reviewed publications reference this trial (live from Europe PMC):

Insight into the Functional Dynamics and Challenges of Exosomes in Pharmaceutical Innovation and Precision Medicine.
Sharma A, Yadav A, Nandy A, Ghatak S. · · 2024 · cited 40× · PMID 38931833 · DOI 10.3390/pharmaceutics16060709
Engineered and Mimicked Extracellular Nanovesicles for Therapeutic Delivery.
Poinsot V, Pizzinat N, Ong-Meang V. · · 2024 · cited 16× · PMID 38607173 · DOI 10.3390/nano14070639
Exosomes and solid cancer therapy: where are we now?
Zemanek T, Danisovic L, Nicodemou A. · · 2025 · cited 15× · PMID 39961904 · DOI 10.1007/s12032-025-02626-3
Immunomodulatory effects and clinical application of exosomes derived from mesenchymal stem cells.
Yi YF, Fan ZQ, Liu C, Ding YT, et al · · 2025 · cited 9× · PMID 40160689 · DOI 10.4252/wjsc.v17.i3.103560
Harnessing the potential of small extracellular vesicle biomarkers for cancer diagnosis and prognosis with advanced analytical technologies.
Tam CWL, Yam JWP. · · 2025 · cited 5× · PMID 40896292 · DOI 10.1515/jtim-2025-0019
The role of exosomes in brain tumors: Mechanisms, diagnosis, and therapeutic prospects.
Falih Shamikh Al-Saedi H, Khalid Younis Al-Bahadli W, Murih Hatab W, Abdolmaleki A. · · 2026 · PMID 42079023 · DOI 10.22038/ijbms.2025.88573.19183
Exosomes in glioma: mechanistic insights on biological, therapeutic, and diagnostic perspective.
Tandon R, Kumar S, Handa M, Srivastava N. · · 2025 · PMID 39957239 · DOI 10.1080/20415990.2025.2466410

Verify or expand the search:

Other trials of Blood sampling

Trials testing the same drug.

NCT07372859 — Women's Heart: Impact of Ultra-endurance and Hormonal Profile on Cardiac and Systemic Inflammatory Parameters in Female · NA · not yet recruiting
NCT07237984 — Colorectal Omics and ofCS Proteoglycans (COCO) in Screening and a Diagnostic Pathway · not yet recruiting
NCT06544018 — Circadian Rhythm Deregulation in Patients With CAPS · NA · recruiting
NCT07245550 — Thyroid and Adrenal Disorders in ICU · not yet recruiting
NCT07033091 — Prevalence of Human Papillomavirus (HPV) in a Healthy Population: A Feasibility Study of Oropharyngeal Cancer Screening · NA · recruiting

Other recruiting trials for Glioma

Currently open trials in the same condition.

NCT07486713 — Olutasidenib DDI Study in Patients With IDH1 Mutation Positive Malignancies · Phase 4 · recruiting
NCT07236840 — Self-administered Remote Neurological Examination Using Mobile Application in Patients With Brain Tumors · recruiting
NCT07450872 — Symptom Cluster Heterogeneity and Gut Microbiota Mechanisms in Childhood Cancer Survivors · recruiting
NCT07405372 — Construction and Application of an IDH Mutation-Targeted PET/MRI Imaging Framework for Precision Diagnosis of Gliomas · recruiting
NCT07338539 — BIO-SHORT: Biologically Guided Short-Course Hypofractionated RT for Poor-Prognosis GBM · Phase 2 · recruiting

Other University Hospital, Limoges trials

Trials by the same sponsor.

NCT07407101 — Impact of Filtration on Autologous Serum Eye Drops · NA · not yet recruiting
NCT07406425 — Evaluation of Efficacy of Coconut Oil Mouth Care for Non-autonomous Hospitalised Elderly People. · NA · not yet recruiting
NCT07436780 — B Lymphocyte Populations in the Pulmonary Microenvironment of Patients Under Mechanical Ventilation With or Without VAP · not yet recruiting
NCT07331298 — Apparent Diffusion Coefficient of the Intervertebral Disc in Children: Pilot Study · not yet recruiting
NCT07019818 — Esmolol Versus Sufentanil on the Quality of Post-cholecystectomy Recovery Laparoscopic Anaesthesia With Orotracheal Intu · Phase 4 · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06116903 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University Hospital, Limoges
Last refreshed: 13 December 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06116903.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing